119 related articles for article (PubMed ID: 12904075)
1. A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.
Swierczek K; Pandey AS; Peters JW; Hengge AC
J Med Chem; 2003 Aug; 46(17):3703-8. PubMed ID: 12904075
[TBL] [Abstract][Full Text] [Related]
2. A nonhydrolyzable analogue of phosphotyrosine, and related aryloxymethano- and aryloxyethano-phosphonic acids as motifs for inhibition of phosphatases.
Iyer S; Younker JM; Czyryca PG; Hengge AC
Bioorg Med Chem Lett; 2004 Dec; 14(23):5931-5. PubMed ID: 15501071
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids.
Lu H; Berkman CE
Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of [difluoro-(3-alkenylphenyl)-methyl]-phosphonic acids on non-crosslinked polystyrene and their evaluation as inhibitors of PTP1B.
Hum G; Lee J; Taylor SD
Bioorg Med Chem Lett; 2002 Dec; 12(23):3471-4. PubMed ID: 12419386
[TBL] [Abstract][Full Text] [Related]
5. Mutation of Arg-166 of alkaline phosphatase alters the thio effect but not the transition state for phosphoryl transfer. Implications for the interpretation of thio effects in reactions of phosphatases.
Holtz KM; Catrina IE; Hengge AC; Kantrowitz ER
Biochemistry; 2000 Aug; 39(31):9451-8. PubMed ID: 10924140
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.
Lee K; Boovanahalli SK; Nam KY; Kang SU; Lee M; Phan J; Wu L; Waugh DS; Zhang ZY; No KT; Lee JJ; Burke TR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4037-42. PubMed ID: 16039123
[TBL] [Abstract][Full Text] [Related]
7. Peptidic alpha-ketocarboxylic acids and sulfonamides as inhibitors of protein tyrosine phosphatases.
Chen YT; Xie J; Seto CT
J Org Chem; 2003 May; 68(10):4123-5. PubMed ID: 12737607
[TBL] [Abstract][Full Text] [Related]
8. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
9. Discovery of protein phosphatase 2C inhibitors by virtual screening.
Rogers JP; Beuscher AE; Flajolet M; McAvoy T; Nairn AC; Olson AJ; Greengard P
J Med Chem; 2006 Mar; 49(5):1658-67. PubMed ID: 16509582
[TBL] [Abstract][Full Text] [Related]
10. Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors.
Lau CK; Bayly CI; Gauthier JY; Li CS; Therien M; Asante-Appiah E; Cromlish W; Boie Y; Forghani F; Desmarais S; Wang Q; Skorey K; Waddleton D; Payette P; Ramachandran C; Kennedy BP; Scapin G
Bioorg Med Chem Lett; 2004 Feb; 14(4):1043-8. PubMed ID: 15013020
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of alpha,alpha-difluorobenzylphosphonic acid derivatives as small molecular inhibitors of protein-tyrosine phosphatase 1B.
Yokomatsu T; Murano T; Umesue I; Soeda S; Shimeno H; Shibuya S
Bioorg Med Chem Lett; 1999 Feb; 9(4):529-32. PubMed ID: 10098656
[TBL] [Abstract][Full Text] [Related]
12. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
13. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of a novel class of protein tyrosine phosphatase inhibitors.
Ibrahimi OA; Wu L; Zhao K; Zhang ZY
Bioorg Med Chem Lett; 2000 Mar; 10(5):457-60. PubMed ID: 10743947
[TBL] [Abstract][Full Text] [Related]
15. [Calix[4]arene methylenebisphosphonic acids: the features of alkaline phosphatases inhibition].
Muzychka OV; Tanchuk VIu; Vovk AI; Muravĭova IV; Cherenok SO; Kal'chenko VI; Kukhar VP
Ukr Biokhim Zh (1999); 2007; 79(6):26-33. PubMed ID: 18712108
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatase activity by positively-charged cyclodextrins.
Ghosh M; Sanders TC; Zhang R; Seto CT
Org Lett; 1999 Dec; 1(12):1945-8. PubMed ID: 10836052
[TBL] [Abstract][Full Text] [Related]
17. Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.
Carneiro VM; Trivella DB; Scorsato V; Beraldo VL; Dias MP; Sobreira TJ; Aparicio R; Pilli RA
Eur J Med Chem; 2015 Jun; 97():42-54. PubMed ID: 25938987
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic studies of protein tyrosine phosphatases YopH and Cdc25A with m-nitrobenzyl phosphate.
McCain DF; Grzyska PK; Wu L; Hengge AC; Zhang ZY
Biochemistry; 2004 Jun; 43(25):8256-64. PubMed ID: 15209522
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of cytostatin analogues.
Bialy L; Waldmann H
Chem Commun (Camb); 2003 Aug; (15):1872-3. PubMed ID: 12932009
[TBL] [Abstract][Full Text] [Related]
20. Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors.
Zhang L; Qiu B; Xiong B; Li X; Li J; Wang X; Li J; Shen J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2118-22. PubMed ID: 17303416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
